EFG International’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
EFG International's SMMT Position: Q3 2026 in Review
EFG International opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 150 shares worth $2.54K. The stake represents ﹤0.01% of the portfolio and ranks #1070 among its holdings.
298 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- EFG International held 150 shares of Summit Therapeutics worth $2.54K as of Q3 2026.
- Summit Therapeutics was a new EFG International position in Q3 2026.
- Summit Therapeutics made up ﹤0.01% of EFG International's portfolio in Q3 2026, its #1070 holding.
- 298 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on EFG International's 13F filing for Q3 2026, filed 16 Nov 2026.